Gilead Sciences, Inc announced that in response to the rapid increase in COVID-19 cases in India, the company is providing its voluntary licensing partners with technical assistance, support for the addition of new local manufacturing facilities and the donation of active pharmaceutical ingredient (API) to rapidly scale up production of remdesivir. Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and children hospitalized with severe disease.
- Read more about Gilead Sciences announces Steps to Expand Availability of Remdesivir in India
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/gilead-sciences-announces-steps-to-expand-availability-of-remdesivir-in-india
No comments:
Post a Comment